Nitazoxanide superiority to placebo to treat moderate COVID-19 – A Pilot prove of concept randomized double-blind clinical trial.-Reference-Cited by-同舟云学术

Nitazoxanide superiority to placebo to treat moderate COVID-19 – A Pilot prove of concept randomized double-blind clinical trial.

Published:2021-07 Issue: Volume:37 Page:100981
ISSN:2589-5370
Container-title:EClinicalMedicine
language:en
Short-container-title:EClinicalMedicine

Author:

Blum Vinicius Fontanesi,Cimerman Sérgio,Hunter James R,Tierno Paulo,Lacerda Acioly,Soeiro Alexandre,Cardoso Florentino,Bellei Nancy Cristina,Maricato Juliana,Mantovani Nathalia,Vassao Marcella,Dias Danilo^ORCID,Galinskas Juliana^ORCID,Janini Luis Mário Ramos,Santos-Oliveira Joanna Reis,Da-Cruz Alda Maria^ORCID,Diaz Ricardo Sobhie

Publisher

Elsevier BV

Subject

General Medicine

Reference51 articles.

1. Valencia D.N. Brief Review on COVID-19: the 2020 pandemic caused by SARS-CoV-2. Cureus. 2020; 12. doi:10.7759/cureus.7386.

2. Clinical phenotypes of SARS-CoV-2: implications for clinicians and researchers;Rello;Eur Respir J,2020

3. Clinical Characteristics of Coronavirus Disease 2019 in China;Guan;N Engl J Med,2020

4. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China;Zhang;Allergy,2020

5. SARS-CoV-2 and COVID-19: from the bench to the bedside;Romagnoli;Physiological Reviews,2020

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. T cell-mediated Immune response and correlates of inflammation and their relationship with COVID-19 clinical severity: not an intuitive guess;BMC Infectious Diseases;2024-06-20

2. Effect of drug therapies on self‐reported chemosensory outcomes after COVID‐19;World Journal of Otorhinolaryngology - Head and Neck Surgery;2024-05-13

3. Why Certain Repurposed Drugs Are Unlikely to Be Effective Antivirals to Treat SARS-CoV-2 Infections;Viruses;2024-04-22

4. Atazanavir/Ritonavir Increased Tizoxanide Exposure from Oral Nitazoxanide through Pharmacokinetic Interaction in Healthy Volunteers;Future Pharmacology;2024-02-22

5. Preclinical and Clinical Investigations of Potential Drugs and Vaccines for COVID-19 Therapy: A Comprehensive Review With Recent Update;Clinical Pathology;2024-01